Angelman syndrome (AS) is a severe neurodevelopmental disorder that results from loss of function of the maternal ubiquitin protein ligase E3A (
Sara Silva-Santos, Geeske M. van Woerden, Caroline F. Bruinsma, Edwin Mientjes, Mehrnoush Aghadavoud Jolfaei, Ben Distel, Steven A. Kushner, Ype Elgersma
Title and authors | Publication | Year |
---|---|---|
Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System
Hegde AN, Timm LE, Sivley CJ, Ramiyaramcharankarthic S, Lowrimore OJ, Hendrix BJ, Grozdanov TG, Anderson WJ |
International Journal of Molecular Sciences | 2025 |
Prenatal gene editing for neurodevelopmental diseases: Ethical considerations
Major RM, Juengst ET |
American Journal of Human Genetics | 2025 |
Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration
Yang X, Huang YW |
International Journal of Molecular Sciences | 2025 |
Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids
Estridge RC, Yagci ZB, Sen D, Johnson TJ, Kelkar GR, Ptacek TS, Simon JM, Keung AJ |
Communications Biology | 2025 |
Overcoming genetic and cellular complexity to study the pathophysiology of X-linked intellectual disabilities.
Martinez D, Jiang E, Zhou Z |
Journal of Neurodevelopmental Disorders | 2024 |
Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1-Related Intellectual Disability
Fenton TA, Haouchine OY, Hallam EL, Smith EM, Jackson KC, Rahbarian D, Canales C, Adhikari A, Nord AS, Ben-Shalom R, Silverman JL |
Research square | 2024 |
Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders.
Hwang HM, Yamashita S, Matsumoto Y, Ito M, Edwards A, Sasaki J, Dutta DJ, Mohammad S, Yamashita C, Wetherill L, Schwantes-An TH, Abreu M, Mahnke AH, Mattson SN, Foroud T, Miranda RC, Chambers C, Torii M, Hashimoto-Torii K |
Molecular Psychiatry | 2024 |
Need of orthogonal approaches in neurological disease modeling in mouse
Bossini L, Sessa A |
Frontiers in molecular neuroscience | 2024 |
Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice
Clarke MT, Remesal L, Lentz L, Tan DJ, Young D, Thapa S, Namuduri SR, Borges B, Kirn G, Valencia J, Lopez ME, Lui JH, Shiow LR, Dindot S, Villeda S, Sanders SJ, MacKenzie TC |
Molecular Therapy | 2024 |
Regional and cellular organization of the autism-associated protein UBE3A/E6AP and its antisense transcript in the brain of the developing rhesus monkey
Gonzalez Ramirez C, Salvador SG, Patel RK, Clark S, Miller NW, James LM, Ringelberg NW, Simon JM, Bennett J, Amaral DG, Burette AC, Philpot BD |
Frontiers in neuroanatomy | 2024 |
Ube3a unsilencer for the potential treatment of Angelman syndrome
Vihma H, Li K, Welton-Arndt A, Smith AL, Bettadapur KR, Gilmore RB, Gao E, Cotney JL, Huang HC, Collins JL, Chamberlain SJ, Lee HM, Aubé J, Philpot BD |
Nature Communications | 2024 |
(1)H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.
Gupta PK, Barak S, Feuermann Y, Goobes G, Kaphzan H |
Molecular autism | 2024 |
Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients
Fujimoto M, Nakamura Y, Hosoki K, Iwaki T, Sato E, Ieda D, Hori I, Negishi Y, Hattori A, Shiraishi H, Saitoh S |
Human Genetics and Genomics Advances | 2024 |
Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics
Aartsma-Rus A, Collin RW, Elgersma Y, Lauffer MC, van Roon-Mom W |
Therapeutic Advances in Rare Disease | 2024 |
Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1-related intellectual disability
Fenton TA, Haouchine OY, Hallam EB, Smith EM, Jackson KC, Rahbarian D, Canales CP, Adhikari A, Nord AS, Ben-Shalom R, Silverman JL |
Translational Psychiatry | 2024 |
Early Intervention services in the era of genomic medicine: setting a research agenda.
MacDuffie KE, Cohn B, Appelbaum P, Brothers KB, Doherty D, Goldenberg AJ, Reynolds E, Smith HS, Wheeler A, Yu JH |
Pediatric research | 2024 |
Widespread Gene Editing in the Brain via In Utero Delivery of mRNA Using Acid-Degradable Lipid Nanoparticles
Gao K, Han H, Cranick MG, Zhao S, Xu S, Yin B, Song H, Hu Y, Clarke MT, Wang D, Wong JM, Zhao Z, Burgstone BW, Farmer DL, Murthy N, Wang A |
ACS Nano | 2024 |
Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome
Dongwon Lee, Wu Chen, Heet Kaku, Xinming Zhuo, Eugene Chao, Armand Soriano, Allen Kuncheria, Stephanie Flores, Joo Hyun Kim, Frank Rigo, Paymaan Jafar-nejad, Arthur Beaudet, Matthew Caudill, Mingshan Xue |
eLife | 2023 |
A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves Angelman syndrome in mice
Jinhui Li, Zhixin Shen, Yajing Liu, Zixiang Yan, Yuanhua Liu, Xiang Lin, Junjie Tang, Ruimin Lv, Guannan Geng, Changyang Zhou, Hui Yang |
Molecular Therapy | 2023 |
Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model
Henriette O'Geen, Ulrika Beitnere, Miranda Garcia, Anna Adhikari, David Cameron, Timothy Fenton, Nycole Copping, Peter Deng, Samantha Lock, Julian Halmai, Isaac Villegas, Jiajian Liu, Danhui Wang, Gregory Davis, Kyle Fink, Jill Silverman, David Segal |
Molecular Therapy | 2023 |
UBE3A expression during early postnatal brain development is required for proper maturation of the dorsomedial striatum
Diana Rotaru, Ilse Wallaard, Maud Vries, Julia Bie, Ype Elgersma |
JCI Insight | 2023 |
Loss of CAMK2G affects intrinsic and motor behavior but has minimal impact on cognitive behavior
Rigter PM, de Konink C, van Woerden GM |
Frontiers in neuroscience | 2023 |
Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
Hong D, Iakoucheva LM |
Translational Psychiatry | 2023 |
Elevated ROS levels during the early development of Angelman syndrome alter the apoptotic capacity of the developing neural precursor cells.
Simchi L, Gupta PK, Feuermann Y, Kaphzan H |
Molecular Psychiatry | 2023 |
Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases
Chaudhary P, Proulx J, Park IW |
Virus Research | 2023 |
Novel epigenetic molecular therapies for imprinting disorders.
Wang SE, Jiang YH |
Molecular Psychiatry | 2023 |
Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice
Xing L, Simon JM, Ptacek TS, Yi JJ, Loo L, Mao H, Wolter JM, McCoy ES, Paranjape SR, Taylor-Blake B, Zylka MJ |
Cell Reports | 2023 |
Hyperexcitability and translational phenotypes in a preclinical model of SYNGAP1 mutations
Silverman JL, Fenton T, Haouchine O, Hallam E, Smith E, Jackson K, Rahbarian D, Canales C, Adhikari A, Nord A, Ben-Shalom R |
Research square | 2023 |
Stem cell models of Angelman syndrome
Camões dos Santos J, Appleton C, Cazaux Mateus F, Covas R, Bekman EP, da Rocha ST |
Frontiers in Cell and Developmental Biology | 2023 |
Contextual fear memory impairment in Angelman syndrome model mice is associated with altered transcriptional responses
Su W, Liu Y, Lam A, Hao X, Baudry M, Bi X |
Scientific Reports | 2023 |
UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies.
Roy B, Amemasor E, Hussain S, Castro K |
2023 | |
Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of Tcf4 expression
H Kim, E Gao, A Draper, N Berens, H Vihma, X Zhang, A Higashi-Howard, K Ritola, J Simon, A Kennedy, B Philpot |
eLife | 2022 |
Adult Camk2a gene reinstatement restores the learning and plasticity deficits of Camk2a
knockout mice
Pomme Rigter, Ilse Wallaard, Mehrnoush Aghadavoud, Jenina Kingma, Laura Post, Minetta Elgersma, Ype Elgersma, Geeske Woerden |
iScience | 2022 |
Molecular and behavioral consequences of Ube3a gene overdosage in mice
A. Punt, Matthew Judson, Michael Sidorov, Naomi S Johnson, Sabine Belder, Dion den Hertog, Courtney R. Davis, Maximillian Feygin, Mehrnoush Aghadavoud, Wilfred IJcken, Ype Elgersma, Benjamin Philpot |
JCI Insight | 2022 |
An in vivo Cell-Based Delivery Platform for Zinc Finger Artificial Transcription Factors in Pre-clinical Animal Models
P Deng, J Halmai, U Beitnere, D Cameron, M Martinez, C Lee, J Waldo, K Thongphanh, A Adhikari, N Copping, S Petkova, R Lee, S Lock, M Palomares, H OGeen, J Carter, C Gonzalez, F Buchanan, J Anderson, F Fierro, J Nolta, A Tarantal, J Silverman, D Segal, K Fink |
Frontiers in molecular neuroscience | 2022 |
Sex‐dependent influence of postweaning environmental enrichment in Angelman syndrome model mice
J Cosgrove, L Kelly, E Kiffmeyer, A Kloth |
Brain and Behavior | 2022 |
A Critical Period for Development of Cerebellar-Mediated Autism-Relevant Social Behavior
J Gibson, C Howland, C Ren, C Howland, A Vernino, P Tsai |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2022 |
Paradoxical Hyperexcitability in Disorders of Neurodevelopment
M Antoine |
Frontiers in molecular neuroscience | 2022 |
AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome
A Campbell, G Morris, A Sanfeliu, J Augusto, E Langa, J Kesavan, N Nguyen, R Conroy, J Worm, L Kielpinski, M Jensen, M Miller, T Kremer, C Reschke, D Henshall |
Molecular Therapy — Nucleic Acids | 2022 |
A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets
Pandya NJ, Meier S, Tyanova S, Terrigno M, Wang C, Punt AM, Mientjes EJ, Vautheny A, Distel B, Kremer T, Elgersma Y, Jagasia R |
Molecular Psychiatry | 2022 |
Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders
Davidson BL, Gao G, Berry-Kravis E, Bradbury AM, Bönnemann C, Buxbaum JD, Corcoran GR, Gray SJ, Gray-Edwards H, Kleiman RJ, Shaywitz AJ, Wang D, Zoghbi HY, Flotte TR, Tauscher-Wisniewski S, Tifft CJ, Sahin M |
Molecular Therapy | 2022 |
An Association Study of DNA Methylation and Gene Expression in Angelman Syndrome: A Bioinformatics Approach
Panov J, Kaphzan H |
International journal of molecular sciences | 2022 |
Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future
Silverman JL, Thurm A, Ethridge SB, Soller MM, Petkova SP, Abel T, Bauman MD, Brodkin ES, Harony-Nicolas H, Wöhr M, Halladay A |
Genes, brain, and behavior | 2022 |
Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
Syding LA, Kubik-Zahorodna A, Nickl P, Novosadova V, Kopkanova J, Kasparek P, Prochazka J, Sedlacek R |
Cells | 2022 |
Open the Window for the Cure of Dravet
Gu B |
Epilepsy Currents | 2022 |
Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome
Tanas JK, Kerr DD, Wang L, Rai A, Wallaard I, Elgersma Y, Sidorov MS |
Translational Psychiatry | 2022 |
Behavioral and brain anatomical analysis of Foxg1 heterozygous mice
Erickson KR, Farmer R, Merritt JK, Miletic Lanaghan Z, Does MD, Ramadass K, Landman BA, Cutting LE, Neul JL |
PloS one | 2022 |
Promising therapeutic aspects in human genetic imprinting disorders
Chao Y, Qin Y, Zou X, Wang X, Hu C, Xia F, Zou C |
Clinical Epigenetics | 2022 |
Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A
Nenninger AW, Willman M, Willman J, Stewart E, Mesidor P, Novoa M, Morrill NK, Alvarez L, Joly-Amado A, Peters MM, Gulick D, Nash KR |
Neurotherapeutics | 2022 |
Newborn screening for neurodevelopmental diseases: Are we there yet?
Chung WK, Berg JS, Botkin JR, Brenner SE, Brosco JP, Brothers KB, Currier RJ, Gaviglio A, Kowtoniuk WE, Olson C, Lloyd-Puryear M, Saarinen A, Sahin M, Shen Y, Sherr EH, Watson MS, Hu Z |
American journal of medical genetics. Part C, Seminars in medical genetics | 2022 |
The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
Viho EM, Punt AM, Distel B, Houtman R, Kroon J, Elgersma Y, Meijer OC |
International journal of molecular sciences | 2022 |
CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice
Ralf S Schmid, Xuefeng Deng, Priyalakshmi Panikker, Msema Msackyi, Camilo Breton, James M. Wilson |
Journal of Clinical Investigation | 2021 |
TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia
Jay Li, Daniel S. Levin, Audrey J Kim, Samuel S Pappas, William Dauer |
Journal of Clinical Investigation | 2021 |
Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman Syndrome mouse model
Claudia Milazzo, Edwin J. Mientjes, Ilse Wallaard, Søren Vestergaard Rasmussen, Kamille Dumong Erichsen, Tejaswini Kakunuri, A.S. Elise van der Sman, Thomas Kremer, Meghan.T. Miller, Marius C. Hoener, Ype Elgersma |
JCI Insight | 2021 |
Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
Matthew C. Judson, Charles Shyng, Jeremy M. Simon, Courtney R. Davis, A. Mattijs Punt, Mirabel Salmon, Noah W. Miller, Kimberly D. Ritola, Ype Elgersma, David G. Amaral, Steven J Gray, Benjamin D. Philpot |
JCI Insight | 2021 |
CNS critical periods: implications for dystonia and other neurodevelopmental disorders
Jay Li, Sumin Kim, Samuel S. Pappas, William Dauer |
JCI Insight | 2021 |
Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells
A Adhikari, NA Copping, J Beegle, DL Cameron, P Deng, H OGeen, DJ Segal, KD Fink, JL Silverman, JS Anderson |
Human Molecular Genetics | 2021 |
Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am−/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade
A Moreira-de-Sá, FQ Gonçalves, JP Lopes, HB Silva, ÂR Tomé, RA Cunha, PM Canas |
Molecular Neurobiology | 2021 |
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Y Elgersma, M Sonzogni |
Developmental medicine and child neurology | 2021 |
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
NA Copping, SM McTighe, KD Fink, JL Silverman |
Neurotherapeutics | 2021 |
Postnatal therapeutic approaches in genetic neurodevelopmental disorders
G Levy, B Barak |
NEURAL REGEN RES | 2021 |
Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
GL Sell, W Xin, EK Cook, MA Zbinden, TB Schaffer, RN OMeally, RN Cole, SS Margolis |
Scientific Reports | 2021 |
Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome
KA Razak, DK Binder, IM Ethell |
Frontiers in Psychiatry | 2021 |
Electrophysiological Characterization of Regular and Burst Firing Pyramidal Neurons of the Dorsal Subiculum in an Angelman Syndrome Mouse Model
PR Rayi, H Kaphzan |
Frontiers in cellular neuroscience | 2021 |
Postnatal Arx transcriptional activity regulates functional properties of PV interneurons
DJ Joseph, MV Deimling, Y Hasegawa, AG Cristancho, RC Ahrens-Nicklas, SL Rogers, R Risbud, AJ McCoy, ED Marsh |
iScience | 2021 |
Epilepsy in Angelman syndrome: A scoping review
D Samanta |
Brain & development | 2021 |
Derepression of inflammation-related genes link to microglia activation and neural maturation defect in a mouse model of Kleefstra syndrome
A Yamada, T Hirasawa, K Nishimura, C Shimura, N Kogo, K Fukuda, M Kato, M Yokomori, T Hayashi, M Umeda, M Yoshimura, Y Iwakura, I Nikaido, S Itohara, Y Shinkai |
iScience | 2021 |
Pre-symptomatic intervention for autism spectrum disorder (ASD): defining a research agenda
R Grzadzinski, D Amso, R Landa, L Watson, M Guralnick, L Zwaigenbaum, G Deák, A Estes, J Brian, K Bath, J Elison, L Abbeduto, J Wolff, J Piven |
Journal of Neurodevelopmental Disorders | 2021 |
Predicting Autism in Infancy
JJ Wolff, J Piven |
Journal of the American Academy of Child and Adolescent Psychiatry | 2021 |
Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
JC Carpenter, G Lignani |
Neurotherapeutics | 2021 |
Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome
EL Berg, SP Petkova, HA Born, A Adhikari, AE Anderson, JL Silverman |
Molecular autism | 2021 |
Genetic therapies for neurological disorders
L FitzPatrick, A Bird |
Human Genetics | 2021 |
CIM6P / IGF ‐2 Receptor Ligands Reverse Deficits in Angelman Syndrome Model Mice
E Cruz, G Descalzi, A Steinmetz, HE Scharfman, A Katzman, CM Alberini |
Autism research : official journal of the International Society for Autism Research | 2020 |
Chronic α1-Na/K-ATPase inhibition reverses the elongation of the axon initial segment of the hippocampal CA1 pyramidal neurons in Angelman syndrome model mice
PR Rayi, AY Bagrov, H Kaphzan |
Neuropsychopharmacology | 2020 |
Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases
E DiCicco-Bloom, JH Millonig |
2020 | |
CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
LA Syding, P Nickl, P Kasparek, R Sedlacek |
Cells | 2020 |
Disrupted Functional and Structural Connectivity in Angelman Syndrome
HM Yoon, Y Jo, WH Shim, JS Lee, TS Ko, JH Koo, MS Yum |
American Journal of Neuroradiology | 2020 |
Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
M Sonzogni, P Zhai, EJ Mientjes, GM van Woerden, Y Elgersma |
Molecular autism | 2020 |
Region and Cell Type Distribution of TCF4 in the Postnatal Mouse Brain
H Kim, NC Berens, NE Ochandarena, BD Philpot |
Frontiers in neuroanatomy | 2020 |
Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome
EL Berg, MC Pride, SP Petkova, RD Lee, NA Copping, Y Shen, A Adhikari, TA Fenton, LR Pedersen, LS Noakes, BJ Nieman, JP Lerch, S Harris, HA Born, MM Peters, P Deng, DL Cameron, KD Fink, U Beitnere, H OGeen, AE Anderson, SV Dindot, KR Nash, EJ Weeber, M Wöhr, J Ellegood, DJ Segal, JL Silverman |
Translational Psychiatry | 2020 |
Novel Insights into the Role of UBE3A in Regulating Apoptosis and Proliferation
L Simchi, J Panov, O Morsy, Y Feuermann, H Kaphzan |
Journal of Clinical Medicine | 2020 |
Molecular Evolution, Neurodevelopmental Roles and Clinical Significance of HECT-Type UBE3 E3 Ubiquitin Ligases
MC Ambrozkiewicz, KJ Cuthill, D Harnett, H Kawabe, V Tarabykin |
Cells | 2020 |
Behavioral Evaluation of Angelman Syndrome Mice at Older Ages
R Dutta, JN Crawley |
Neuroscience | 2020 |
Developmental studies in fragile X syndrome
KA Razak, KC Dominick, CA Erickson |
Journal of Neurodevelopmental Disorders | 2020 |
Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA
JM Wolter, H Mao, G Fragola, JM Simon, JL Krantz, HO Bazick, B Oztemiz, JL Stein, MJ Zylka |
Nature | 2020 |
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
TJ Turner, C Zourray, S Schorge, G Lignani |
Journal of Neurochemistry | 2020 |
Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A
D Sen, A Voulgaropoulos, Z Drobna, AJ Keung |
Stem Cell Reports | 2020 |
Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders
VB Quick, B Wang, MW State |
Neuropsychopharmacology | 2020 |
Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders
MJ Ottenhoff, LC Krab, Y Elgersma |
eNeuro | 2020 |
Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome
MN Schultz, JN Crawley |
Learning & memory (Cold Spring Harbor, N.Y.) | 2020 |
Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice
Bin Gu, Manhua zhu, Madison Glass, Marie Rougié, Viktoriya D Nikolova, Sheryl S. Moy, Paul R. Carney, Benjamin D. Philpot |
Journal of Clinical Investigation | 2019 |
The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions
N Khatri, HY Man |
Frontiers in molecular neuroscience | 2019 |
Circadian biology and sleep in monogenic neurological disorders and its potential application in drug discovery
S Shi, CH Johnson |
Current Opinion in Behavioral Sciences | 2019 |
UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease
SJ Lopez, DJ Segal, JM LaSalle |
Frontiers in molecular neuroscience | 2019 |
UBE3A regulates the transcription of IRF, an antiviral immunity
R Furumai, K Tamada, X Liu, T Takumi |
Human Molecular Genetics | 2019 |
Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
M Sonzogni, J Hakonen, MB Kleijn, S Silva-Santos, MC Judson, BD Philpot, GM van Woerden, Y Elgersma |
Molecular autism | 2019 |
The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons
I Tonazzini, GM Woerden, C Masciullo, EJ Mientjes, Y Elgersma, M Cecchini |
Molecular autism | 2019 |
Prenatal treatment path for angelman syndrome and other neurodevelopmental disorders
MJ Zylka |
Autism research : official journal of the International Society for Autism Research | 2019 |
Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse
V Kumar, T Joshi, N Vatsa, BK Singh, NR Jana |
Frontiers in molecular neuroscience | 2019 |
Apparent Genetic Rescue of Adult Shank3 Exon 21 Insertion Mutation Mice Tempered by Appropriate Control Experiments
HE Speed, M Kouser, Z Xuan, S Liu, A Duong, CM Powell |
eNeuro | 2019 |
Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice
Bin Gu, Kelly Carstens, Matthew Judson, Katherine Dalton, Marie Rougié, Ellen Clark, Serena M. Dudek, Benjamin D. Philpot |
Journal of Clinical Investigation | 2018 |
Autism spectrum disorder: prospects for treatment using gene therapy
M Benger, M Kinali, ND Mazarakis |
Molecular autism | 2018 |
A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
AJ George, YC Hoffiz, AJ Charles, Y Zhu, AM Mabb |
Frontiers in Genetics | 2018 |
Hippocampal deficits in neurodevelopmental disorders
Y Li, M Shen, ME Stockton, X Zhao |
Neurobiology of Learning and Memory | 2018 |
Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders
JJ Fink, ES Levine |
Frontiers in neurology | 2018 |
Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
T Wang, GM van Woerden, Y Elgersma, JG Borst |
Frontiers in cellular neuroscience | 2018 |
Taurine Administration Recovers Motor and Learning Deficits in an Angelman Syndrome Mouse Model
S Guzzetti, L Calzari, L Buccarello, V Cesari, I Toschi, S Cattaldo, A Mauro, F Pregnolato, S Mazzola, S Russo |
International journal of molecular sciences | 2018 |
Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome
MS Sidorov, MC Judson, H Kim, M Rougie, AI Ferrer, VD Nikolova, NV Riddick, SS Moy, BD Philpot |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2018 |
A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
M Sonzogni, I Wallaard, SS Santos, J Kingma, D du Mee, GM van Woerden, Y Elgersma |
Molecular autism | 2018 |
Sensitive Periods for Cerebellar-Mediated Autistic-like Behaviors
PT Tsai, S Rudolph, C Guo, J Ellegood, JM Gibson, SM Schaeffer, J Mogavero, JP Lerch, W Regehr, M Sahin |
Cell Reports | 2018 |
Adult Ube3a Gene Reinstatement Restores the Electrophysiological Deficits of Prefrontal Cortex Layer 5 Neurons in a Mouse Model of Angelman Syndrome
DC Rotaru, GM van Woerden, I Wallaard, Y Elgersma |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2018 |
Epigenetic and Cellular Diversity in the Brain through Allele-Specific Effects
WC Huang, K Bennett, C Gregg |
Trends in Neurosciences | 2018 |
Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models
J Schreiber, LA Grimbergen, I Overwater, T der Vaart, J Stedehouder, AJ Schuhmacher, C Guerra, SA Kushner, D Jaarsma, Y Elgersma |
Scientific Reports | 2017 |
Cellular and Circuitry Bases of Autism: Lessons Learned from the Temporospatial Manipulation of Autism Genes in the Brain
SW Hulbert, Y Jiang |
Neuroscience Bulletin | 2017 |
Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
M Sato |
Frontiers in cellular neuroscience | 2017 |
Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury
JP Reynolds, EM Jimenez-Mateos, L Cao, F Bian, M Alves, SF Miller-Delaney, A Zhou, DC Henshall |
Neurochemical Research | 2017 |
E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration
A Upadhyay, V Joshi, A Amanullah, R Mishra, N Arora, A Prasad, A Mishra |
Frontiers in molecular neuroscience | 2017 |
Maturation, Refinement, and Serotonergic Modulation of Cerebellar Cortical Circuits in Normal Development and in Murine Models of Autism
E Hoxha, P Lippiello, B Scelfo, F Tempia, M Ghirardi, MC Miniaci |
Neural plasticity | 2017 |
Ube3a loss increases excitability and blunts orientation tuning in the visual cortex of Angelman syndrome model mice
ML Wallace, GM van Woerden, Y Elgersma, SL Smith, BD Philpot |
Journal of neurophysiology | 2017 |
Enhanced Nociception in Angelman Syndrome Model Mice
ES McCoy, B Taylor-Blake, M Aita, JM Simon, BD Philpot, MJ Zylka |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2017 |
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
EM Berry-Kravis, L Lindemann, AE Jønch, G Apostol, MF Bear, RL Carpenter, JN Crawley, A Curie, VD Portes, F Hossain, F Gasparini, B Gomez-Mancilla, D Hessl, E Loth, SH Scharf, PP Wang, FV Raison, R Hagerman, W Spooren, S Jacquemont |
Nature Reviews Drug Discovery | 2017 |
The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization
N Khatri, JP Gilbert, Y Huo, R Sharaflari, M Nee, H Qiao, HY Man |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2017 |
New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain
JD Perez, ND Rubinstein, C Dulac |
Annual Review of Neuroscience | 2016 |
Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links
SW Hulbert, YH Jiang |
Neuroscience | 2016 |
Angelman syndrome — insights into a rare neurogenetic disorder
K Buiting, C Williams, B Horsthemke |
Nature Reviews Neurology | 2016 |
Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation
F Du, MV Nguyen, A Karten, CA Felice, G Mandel, N Ballas |
Human Molecular Genetics | 2016 |
GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility
MC Judson, ML Wallace, MS Sidorov, AC Burette, B Gu, GM van Woerden, IF King, JE Han, MJ Zylka, Y Elgersma, RJ Weinberg, BD Philpot |
Neuron | 2016 |
Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice
S Peter, MM Brinke, J Stedehouder, CM Reinelt, B Wu, H Zhou, K Zhou, HJ Boele, SA Kushner, MG Lee, MJ Schmeisser, TM Boeckers, M Schonewille, FE Hoebeek, CI de Zeeuw |
Nature Communications | 2016 |
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model
Caroline Bruinsma, Martijn Schonewille, Zhenyu Gao, Eleonora Aronica, Matthew Judson, Benjamin D. Philpot, Freek Hoebeek, Geeske van Woerden, Chris I. De Zeeuw, Ype Elgersma |
Journal of Clinical Investigation | 2015 |
Potential therapeutic approaches for Angelman syndrome
X Bi, J Sun, AX Ji, M Baudry |
Expert Opinion on Therapeutic Targets | 2015 |
From UBE3A to Angelman syndrome: a substrate perspective
GL Sell, SS Margolis |
Frontiers in neuroscience | 2015 |
Neurodevelopmental disease: A molecular tightrope
Y Elgersma |
Nature | 2015 |
Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders
JM LaSalle, LT Reiter, SJ Chamberlain |
Epigenomics | 2015 |
Mitochondrial Superoxide Contributes to Hippocampal Synaptic Dysfunction and Memory Deficits in Angelman Syndrome Model Mice
E Santini, KL Turner, AB Ramaraj, MP Murphy, E Klann, H Kaphzan |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2015 |